Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Alliance for Clinical Trials in Oncology
University of Texas Southwestern Medical Center
University of Michigan Rogel Cancer Center
University of California, San Francisco